Annual Operating Expenses
$228.63 M
+$621.00 K+0.27%
31 December 2023
Summary:
Esperion Therapeutics annual total operating expenses is currently $228.63 million, with the most recent change of +$621.00 thousand (+0.27%) on 31 December 2023. During the last 3 years, it has fallen by -$117.92 million (-34.03%). ESPR annual operating expenses is now -34.03% below its all-time high of $346.55 million, reached on 31 December 2020.ESPR Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$50.37 M
-$5.27 M-9.48%
30 September 2024
Summary:
Esperion Therapeutics quarterly total operating expenses is currently $50.37 million, with the most recent change of -$5.27 million (-9.48%) on 30 September 2024. Over the past year, it has increased by +$2.25 million (+4.67%). ESPR quarterly operating expenses is now -51.34% below its all-time high of $103.52 million, reached on 31 December 2020.ESPR Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ESPR Operating Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +0.3% | +4.7% |
3 y3 years | -34.0% | -22.0% |
5 y5 years | +11.8% | -24.5% |
ESPR Operating Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -34.0% | +0.3% | -23.6% | +4.7% |
5 y | 5 years | -34.0% | +11.8% | -51.3% | +4.7% |
alltime | all time | -34.0% | +2149.3% | -51.3% | +2231.7% |
Esperion Therapeutics Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $50.37 M(-9.5%) |
June 2024 | - | $55.65 M(+0.5%) |
Mar 2024 | - | $55.39 M(-12.3%) |
Dec 2023 | $228.63 M(+0.3%) | $63.16 M(+31.3%) |
Sept 2023 | - | $48.13 M(-14.2%) |
June 2023 | - | $56.06 M(-8.5%) |
Mar 2023 | - | $61.28 M(+7.2%) |
Dec 2022 | $228.01 M(-21.6%) | $57.17 M(+5.7%) |
Sept 2022 | - | $54.10 M(-12.8%) |
June 2022 | - | $62.04 M(+13.4%) |
Mar 2022 | - | $54.70 M(-17.1%) |
Dec 2021 | $290.96 M(-16.0%) | $65.95 M(+2.1%) |
Sept 2021 | - | $64.60 M(-9.5%) |
June 2021 | - | $71.39 M(-19.8%) |
Mar 2021 | - | $89.02 M(-14.0%) |
Dec 2020 | $346.55 M(+43.5%) | $103.52 M(+23.1%) |
Sept 2020 | - | $84.11 M(+1.7%) |
June 2020 | - | $82.67 M(+8.4%) |
Mar 2020 | - | $76.25 M(+27.2%) |
Dec 2019 | $241.47 M(+18.0%) | $59.95 M(-10.2%) |
Sept 2019 | - | $66.75 M(+18.6%) |
June 2019 | - | $56.28 M(-3.8%) |
Mar 2019 | - | $58.49 M(-3.6%) |
Dec 2018 | $204.59 M(+21.1%) | $60.65 M(+19.9%) |
Sept 2018 | - | $50.56 M(+8.8%) |
June 2018 | - | $46.48 M(-0.9%) |
Mar 2018 | - | $46.89 M(+21.2%) |
Dec 2017 | $168.98 M | $38.70 M(-15.4%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2017 | - | $45.74 M(+4.8%) |
June 2017 | - | $43.66 M(+6.8%) |
Mar 2017 | - | $40.89 M(+39.6%) |
Dec 2016 | $76.15 M(+52.2%) | $29.29 M(+65.3%) |
Sept 2016 | - | $17.71 M(+23.6%) |
June 2016 | - | $14.33 M(-3.3%) |
Mar 2016 | - | $14.82 M(+12.0%) |
Dec 2015 | $50.04 M(+38.1%) | $13.23 M(+2.4%) |
Sept 2015 | - | $12.92 M(+3.7%) |
June 2015 | - | $12.46 M(+9.1%) |
Mar 2015 | - | $11.43 M(+21.8%) |
Dec 2014 | $36.22 M(+59.2%) | $9.38 M(-3.3%) |
Sept 2014 | - | $9.70 M(+4.8%) |
June 2014 | - | $9.25 M(+17.3%) |
Mar 2014 | - | $7.89 M(-19.0%) |
Dec 2013 | $22.76 M(+123.0%) | $9.74 M(+80.1%) |
Sept 2013 | - | $5.41 M(+26.6%) |
June 2013 | - | $4.27 M(+27.8%) |
Mar 2013 | - | $3.34 M(+54.8%) |
Dec 2012 | $10.20 M(+0.4%) | $2.16 M(-27.8%) |
Sept 2012 | - | $2.99 M(+4.4%) |
June 2012 | - | $2.86 M(+30.8%) |
Mar 2012 | - | $2.19 M |
Dec 2011 | $10.16 M(-65.2%) | - |
Dec 2002 | $29.24 M(-0.3%) | - |
Dec 2001 | $29.33 M(+9.5%) | - |
Dec 2000 | $26.79 M(+129.3%) | - |
Dec 1999 | $11.69 M | - |
FAQ
- What is Esperion Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Esperion Therapeutics?
- What is Esperion Therapeutics annual operating expenses year-on-year change?
- What is Esperion Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Esperion Therapeutics?
- What is Esperion Therapeutics quarterly operating expenses year-on-year change?
What is Esperion Therapeutics annual total operating expenses?
The current annual operating expenses of ESPR is $228.63 M
What is the all time high annual operating expenses for Esperion Therapeutics?
Esperion Therapeutics all-time high annual total operating expenses is $346.55 M
What is Esperion Therapeutics annual operating expenses year-on-year change?
Over the past year, ESPR annual total operating expenses has changed by +$621.00 K (+0.27%)
What is Esperion Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of ESPR is $50.37 M
What is the all time high quarterly operating expenses for Esperion Therapeutics?
Esperion Therapeutics all-time high quarterly total operating expenses is $103.52 M
What is Esperion Therapeutics quarterly operating expenses year-on-year change?
Over the past year, ESPR quarterly total operating expenses has changed by +$2.25 M (+4.67%)